A1 Refereed original research article in a scientific journal
Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris
Authors: Aspatwar Ashok, Barker Harlan, Aisala Heidi, Zueva Ksenia, Kuuslahti Marianne, Tolvanen Martti, Primmer Craig R, Lumme Jaakko, Bonardi Alessandro, Tripathi Amit, Parkkila Seppo, Supuran Claudiu T
Publisher: TAYLOR & FRANCIS LTD
Publication year: 2022
Journal: Journal of Enzyme Inhibition and Medicinal Chemistry
Journal name in source: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Journal acronym: J ENZYM INHIB MED CH
Volume: 37
Issue: 1
First page : 1577
Last page: 1586
Number of pages: 10
ISSN: 1475-6366
eISSN: 1475-6374
DOI: https://doi.org/10.1080/14756366.2022.2080818
Web address : https://www.tandfonline.com/doi/full/10.1080/14756366.2022.2080818
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/175821691
A β-class carbonic anhydrase (CA, EC 4.2.1.1) was cloned from the genome of the Monogenean platyhelminth Gyrodactylus salaris, a parasite of Atlantic salmon. The new enzyme, GsaCAβ has a significant catalytic activity for the physiological reaction, CO2 + H2O ⇋ HCO3− + H+ with a kcat of 1.1 × 105 s−1 and a kcat/Km of 7.58 × 106 M−1 × s−1. This activity was inhibited by acetazolamide (KI of 0.46 µM), a sulphonamide in clinical use, as well as by selected inorganic anions and small molecules. Most tested anions inhibited GsaCAβ at millimolar concentrations, but sulfamide (KI of 81 µM), N,N-diethyldithiocarbamate (KI of 67 µM) and sulphamic acid (KI of 6.2 µM) showed a rather efficient inhibitory action. There are currently very few non-toxic agents effective in combating this parasite. GsaCAβ is subsequently proposed as a new drug target for which effective inhibitors can be designed.
Downloadable publication This is an electronic reprint of the original article. |